BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 20817595)

  • 1. Restless legs syndrome: understanding its consequences and the need for better treatment.
    Earley CJ; Silber MH
    Sleep Med; 2010 Oct; 11(9):807-15. PubMed ID: 20817595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restless legs syndrome in end-stage renal disease.
    Gigli GL; Adorati M; Dolso P; Piani A; Valente M; Brotini S; Budai R
    Sleep Med; 2004 May; 5(3):309-15. PubMed ID: 15165541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restless legs syndrome, insomnia and quality of life in patients on maintenance dialysis.
    Mucsi I; Molnar MZ; Ambrus C; Szeifert L; Kovacs AZ; Zoller R; Barótfi S; Remport A; Novak M
    Nephrol Dial Transplant; 2005 Mar; 20(3):571-7. PubMed ID: 15671074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.
    García-Borreguero D; Allen RP; Kohnen R; Högl B; Trenkwalder C; Oertel W; Hening WA; Paulus W; Rye D; Walters A; Winkelmann J; Earley CJ;
    Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.
    Walters AS; Ondo WG; Dreykluft T; Grunstein R; Lee D; Sethi K;
    Mov Disord; 2004 Dec; 19(12):1414-23. PubMed ID: 15390050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
    Fulda S; Wetter TC
    Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Restless legs syndrome. Features and impact on sleep].
    Gabaldón Torres L; Salas Felipe J; Fernández Domínguez J; Vivancos Matellanos F; Izal E; Arpa Gutiérrez F
    Neurologia; 2009 May; 24(4):230-4. PubMed ID: 19603292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restless legs syndrome in patients on dialysis.
    Al-Jahdali HH; Al-Qadhi WA; Khogeer HA; Al-Hejaili FF; Al-Ghamdi SM; Al Sayyari AA
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):378-85. PubMed ID: 19414938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition, diagnosis, and treatment of restless legs syndrome.
    Smith JE; Tolson JM
    J Am Acad Nurse Pract; 2008 Aug; 20(8):396-401. PubMed ID: 18786013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Restless-legs syndrome].
    Karroum E; Konofal E; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):701-21. PubMed ID: 18656214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periodic limb movement disorder and restless legs syndrome in dialysis patients.
    Rijsman RM; de Weerd AW; Stam CJ; Kerkhof GA; Rosman JB
    Nephrology (Carlton); 2004 Dec; 9(6):353-61. PubMed ID: 15663636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging drugs for restless legs syndrome.
    Fulda S; Wetter TC
    Expert Opin Emerg Drugs; 2005 Aug; 10(3):537-52. PubMed ID: 16083328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current guidelines and standards of practice for restless legs syndrome.
    Hening WA
    Am J Med; 2007 Jan; 120(1 Suppl 1):S22-7. PubMed ID: 17198767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of RLS.
    Hening WA; Allen RP; Chaudhuri KR; Hornyak M; Lee HB; Winkelman J; Yoakum R
    Mov Disord; 2007; 22 Suppl 18():S395-400. PubMed ID: 18081162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restless legs syndrome: a review of diagnosis and management in primary care.
    Bogan RK; Cheray JA
    Postgrad Med; 2013 May; 125(3):99-111. PubMed ID: 23748511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restless legs syndrome: an overview of the current understanding and management.
    Garcia-Borreguero D; Odin P; Schwarz C
    Acta Neurol Scand; 2004 May; 109(5):303-17. PubMed ID: 15080856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restless legs syndrome and its relationship with insomnia symptoms and daytime distress: epidemiological survey in Sweden.
    Broman JE; Mallon L; Hetta J
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):472-5. PubMed ID: 18778446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restless legs syndrome, insomnia, and quality of life after renal transplantation.
    Molnar MZ; Novak M; Szeifert L; Ambrus C; Keszei A; Koczy A; Lindner A; Barotfi S; Szentkiralyi A; Remport A; Mucsi I
    J Psychosom Res; 2007 Dec; 63(6):591-7. PubMed ID: 18061749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic augmentation of restless legs syndrome.
    García-Borreguero D; Williams AM
    Sleep Med Rev; 2010 Oct; 14(5):339-46. PubMed ID: 20219397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of restless legs syndrome--methodological approaches for use in practice and clinical trials.
    Kohnen R; Allen RP; Benes H; Garcia-Borreguero D; Hening WA; Stiasny-Kolster K; Zucconi M
    Mov Disord; 2007; 22 Suppl 18():S485-94. PubMed ID: 17534967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.